
- Pharmaceutical Technology-01-02-2021
- Volume 45
- Issue 1
Ultra-Low-Temperature Freezers for COVID-19 Vaccines
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines.
Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines. Designed with enhanced robustness, efficiency, and ergonomics, the freezers come equipped with vacuum panels for high levels of insulation to uphold a temperature of -80 ºC with ambient temperatures up to +28 ºC. Instead of using polyurethane foam like many standard freezers, Boreas feature a thinner inner insulation for an enlarged storage capacity of up to 30%. Additionally, the freezers use high purity natural refrigerant CFC free gases that contribute to environment preservation.
Articles in this issue
almost 5 years ago
Bringing Bio/Pharma’s “New Normal” Into Focusalmost 5 years ago
The Outlook for a Year of Changealmost 5 years ago
Compensation Does Not Necessarily Align With Job Satisfactionalmost 5 years ago
Talent-Driven Market for Laboratory Techniciansalmost 5 years ago
ECHA’s Microplastics Use Restriction—Impact on Pharmaceuticalsalmost 5 years ago
FDA Ends 2020 with High Drug Approval Ratealmost 5 years ago
Overcoming Biologic Drug Formulation Hurdlesalmost 5 years ago
Choosing a Cleanroom Infrastructure Technologyalmost 5 years ago
COVID-19 Vaccine Distribution: Preparing for the Unexpectedalmost 5 years ago
FDA Inspections Remain Stalled During the COVID-19 PandemicNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.





